Sentences with phrase «groups at pharmaceutical companies»

Finch explained to him the difference in mindsets between the research - and - development teams and the marketing groups at pharmaceutical companies.

Not exact matches

At biotechnology and pharmaceutical companies, affinity groups have been integrated into the business fabric of many companies.

Lab tests identified the most effective ones, and the group's partners at pharmaceutical company Bristol - Myers Squibb found that the compounds also blocked HIV reverse transcriptase, an enzyme that's key to the virus's ability to copy itself.

Former pharmaceutical executive Martin Shkreli has congratulated a group of Australian students who reproduced the active ingredient for a life - saving, anti-parasitic drug at the center of a drug - price controversy involving his former company.

The Clinical Research Forum, a consortium of leading academic health centers headed by Crowley, has asked pharmaceutical companies for a combined $ 10 million per year for 3 years (the minimum length of time the group expects NIH budget problems to persist), to create «bridging awards» for young investigators who have completed an NIH clinical research training grant, have narrowly missed receiving funding for an independent grant, and are employed at institutions that will match the funding and allow recipients to spend at least 75 % of their time on research.

One of the core beliefs at ISB is that medicine will become more and more personalized, with people sequencing their own genes and pharmaceutical companies developing drugs for groups with certain genetic characteristics.

Now let's look at the new companies, which fall into six main groups: Consumer Oriented, Banks, Pharmaceuticals, Information Technology, Industrials, and Internet.

Mr. Damon's commitment to raise $ 1 million through that group and the OneXOne Foundation in the next year was one of a bundle of pledges aimed at water and sanitation from individuals, charities and companies totalling about $ 400 million (including a $ 200 million pledge by Napo Pharmaceuticals to «complete the clinical development of crofelemer, a drug that has potential to treat pediatric diarrhea, and provide it at cost to partner organizations for distribution in the areas with the highest mortality and morbidity associated with diarrheal diseases.»)

This September, former RB group GC Claire Debney will start at pharmaceutical giant Shire in a newly - created role of director of legal strategy, part of which will see her overhaul the FTSE 100 company's intranet and look at contract automation.